Microbot Depreciation vs End Period Cash Flow Analysis

MBOT Stock

USD 1.93 0.06 3.21%

Microbot Medical financial indicator trend analysis is infinitely more than just investigating Microbot Medical recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Microbot Medical is a good investment. Please check the relationship between Microbot Medical Depreciation and its End Period Cash Flow accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbot Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.

Depreciation vs End Period Cash Flow

Depreciation vs End Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Microbot Medical Depreciation account and End Period Cash Flow. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Microbot Medical's Depreciation and End Period Cash Flow is 0.4. Overlapping area represents the amount of variation of Depreciation that can explain the historical movement of End Period Cash Flow in the same time period over historical financial statements of Microbot Medical, assuming nothing else is changed. The correlation between historical values of Microbot Medical's Depreciation and End Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Depreciation of Microbot Medical are associated (or correlated) with its End Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when End Period Cash Flow has no effect on the direction of Depreciation i.e., Microbot Medical's Depreciation and End Period Cash Flow go up and down completely randomly.

Correlation Coefficient

0.4

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Depreciation

Depreciation indicates how much of Microbot Medical value has been used up. For tax purposes Microbot Medical can deduct the cost of the tangible assets it purchases as business expenses. However, Microbot Medical must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.

End Period Cash Flow

Most indicators from Microbot Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Microbot Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbot Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.At this time, Microbot Medical's Issuance Of Capital Stock is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to about 75.4 K in 2025, whereas Enterprise Value Over EBITDA is likely to drop (1.29) in 2025.

Microbot Medical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Property Plant And Equipment Gross	Common Stock Total Equity	Common Stock	Short Term Investments	Current Deferred Revenue
Total Assets		0.57	0.31	0.56	0.65	0.69	-0.75	-0.61	0.03	0.9	0.74	0.55	0.97	-0.24	-0.49	0.72	0.54	0.64	0.7	0.98	0.58	0.37	0.39	0.36	0.01	-0.18
Short Long Term Debt Total	0.57		0.7	0.85	-0.13	0.94	-0.1	-0.76	-0.03	0.61	0.68	0.12	0.47	-0.1	-0.47	0.84	0.09	0.75	0.88	0.47	0.96	0.52	0.48	0.46	-0.39	-0.25
Other Current Liab	0.31	0.7		0.9	-0.46	0.74	0.31	-0.87	0.35	0.12	0.69	0.36	0.12	0.14	-0.3	0.77	-0.12	0.86	0.84	0.15	0.59	0.29	0.6	0.62	-0.22	-0.47
Total Current Liabilities	0.56	0.85	0.9		-0.19	0.86	0.0	-0.86	0.28	0.45	0.74	0.4	0.42	0.12	-0.33	0.83	0.21	0.86	0.92	0.44	0.79	0.38	0.56	0.56	-0.31	-0.41
Total Stockholder Equity	0.65	-0.13	-0.46	-0.19		-0.02	-0.93	0.16	-0.17	0.68	0.07	0.26	0.78	-0.25	-0.07	-0.05	0.63	-0.12	-0.09	0.77	-0.07	0.04	-0.17	-0.2	0.25	0.17
Property Plant And Equipment Net	0.69	0.94	0.74	0.86	-0.02		-0.18	-0.85	0.14	0.65	0.83	0.36	0.55	-0.16	-0.55	0.89	0.12	0.85	0.92	0.57	0.86	0.64	0.63	0.62	-0.22	-0.19
Net Debt	-0.75	-0.1	0.31	0.0	-0.93	-0.18		-0.02	0.01	-0.85	-0.23	-0.36	-0.84	0.35	0.29	-0.14	-0.66	-0.01	-0.11	-0.84	-0.15	-0.17	-0.03	0.01	-0.04	-0.18
Retained Earnings	-0.61	-0.76	-0.87	-0.86	0.16	-0.85	-0.02		-0.25	-0.39	-0.91	-0.56	-0.44	0.07	0.53	-0.95	-0.01	-1.0	-0.96	-0.45	-0.68	-0.37	-0.77	-0.77	0.14	0.47
Accounts Payable	0.03	-0.03	0.35	0.28	-0.17	0.14	0.01	-0.25		-0.02	0.34	0.64	-0.08	0.07	-0.17	0.14	-0.07	0.25	0.19	-0.08	-0.07	0.2	0.56	0.58	0.05	0.06
Cash	0.9	0.61	0.12	0.45	0.68	0.65	-0.85	-0.39	-0.02		0.55	0.35	0.93	-0.31	-0.46	0.55	0.57	0.41	0.55	0.92	0.63	0.41	0.27	0.24	-0.17	0.01
Non Current Assets Total	0.74	0.68	0.69	0.74	0.07	0.83	-0.23	-0.91	0.34	0.55		0.67	0.58	-0.15	-0.64	0.95	0.07	0.92	0.91	0.58	0.64	0.48	0.77	0.76	-0.02	-0.28
Non Currrent Assets Other	0.55	0.12	0.36	0.4	0.26	0.36	-0.36	-0.56	0.64	0.35	0.67		0.43	-0.3	-0.56	0.49	0.39	0.57	0.49	0.46	0.05	0.22	0.76	0.75	0.13	-0.09
Cash And Short Term Investments	0.97	0.47	0.12	0.42	0.78	0.55	-0.84	-0.44	-0.08	0.93	0.58	0.43		-0.23	-0.38	0.57	0.58	0.47	0.54	0.99	0.51	0.29	0.21	0.18	0.04	-0.12
Net Receivables	-0.24	-0.1	0.14	0.12	-0.25	-0.16	0.35	0.07	0.07	-0.31	-0.15	-0.3	-0.23		0.73	-0.13	-0.21	-0.04	-0.09	-0.25	-0.01	-0.14	-0.29	-0.23	0.01	-0.22
Common Stock Shares Outstanding	-0.49	-0.47	-0.3	-0.33	-0.07	-0.55	0.29	0.53	-0.17	-0.46	-0.64	-0.56	-0.38	0.73		-0.63	-0.13	-0.51	-0.57	-0.39	-0.4	-0.5	-0.66	-0.59	-0.07	-0.21
Non Current Liabilities Total	0.72	0.84	0.77	0.83	-0.05	0.89	-0.14	-0.95	0.14	0.55	0.95	0.49	0.57	-0.13	-0.63		0.06	0.95	0.98	0.56	0.8	0.44	0.7	0.68	-0.15	-0.36
Other Current Assets	0.54	0.09	-0.12	0.21	0.63	0.12	-0.66	-0.01	-0.07	0.57	0.07	0.39	0.58	-0.21	-0.13	0.06		0.03	0.13	0.64	0.07	-0.02	-0.02	-0.06	-0.13	0.0
Other Stockholder Equity	0.64	0.75	0.86	0.86	-0.12	0.85	-0.01	-1.0	0.25	0.41	0.92	0.57	0.47	-0.04	-0.51	0.95	0.03		0.96	0.48	0.68	0.37	0.76	0.76	-0.13	-0.47
Total Liab	0.7	0.88	0.84	0.92	-0.09	0.92	-0.11	-0.96	0.19	0.55	0.91	0.49	0.54	-0.09	-0.57	0.98	0.13	0.96		0.55	0.83	0.44	0.68	0.67	-0.21	-0.39
Total Current Assets	0.98	0.47	0.15	0.44	0.77	0.57	-0.84	-0.45	-0.08	0.92	0.58	0.46	0.99	-0.25	-0.39	0.56	0.64	0.48	0.55		0.5	0.29	0.23	0.2	0.02	-0.12
Short Term Debt	0.58	0.96	0.59	0.79	-0.07	0.86	-0.15	-0.68	-0.07	0.63	0.64	0.05	0.51	-0.01	-0.4	0.8	0.07	0.68	0.83	0.5		0.48	0.36	0.35	-0.33	-0.24
Property Plant And Equipment Gross	0.37	0.52	0.29	0.38	0.04	0.64	-0.17	-0.37	0.2	0.41	0.48	0.22	0.29	-0.14	-0.5	0.44	-0.02	0.37	0.44	0.29	0.48		0.33	0.3	0.38	0.58
Common Stock Total Equity	0.39	0.48	0.6	0.56	-0.17	0.63	-0.03	-0.77	0.56	0.27	0.77	0.76	0.21	-0.29	-0.66	0.7	-0.02	0.76	0.68	0.23	0.36	0.33		1.0	-0.22	-0.23
Common Stock	0.36	0.46	0.62	0.56	-0.2	0.62	0.01	-0.77	0.58	0.24	0.76	0.75	0.18	-0.23	-0.59	0.68	-0.06	0.76	0.67	0.2	0.35	0.3	1.0		-0.23	-0.27
Short Term Investments	0.01	-0.39	-0.22	-0.31	0.25	-0.22	-0.04	0.14	0.05	-0.17	-0.02	0.13	0.04	0.01	-0.07	-0.15	-0.13	-0.13	-0.21	0.02	-0.33	0.38	-0.22	-0.23		0.58
Current Deferred Revenue	-0.18	-0.25	-0.47	-0.41	0.17	-0.19	-0.18	0.47	0.06	0.01	-0.28	-0.09	-0.12	-0.22	-0.21	-0.36	0.0	-0.47	-0.39	-0.12	-0.24	0.58	-0.23	-0.27	0.58

Click cells to compare fundamentals

Microbot Medical Account Relationship Matchups

Microbot Medical fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	26.3M	16.8M	9.5M	8.3M	7.5M	7.1M
Short Long Term Debt Total	813K	680K	462K	231K	207.9K	197.5K
Other Current Liab	696K	1.4M	1.7M	3.2M	3.7M	2.6M
Total Current Liabilities	1.3M	2.0M	2.1M	3.8M	4.4M	4.8M
Total Stockholder Equity	24.3M	14.4M	7.3M	4.5M	4.1M	3.8M
Property Plant And Equipment Net	1.0M	888K	723K	406K	365.4K	347.1K
Net Debt	(18.8M)	(12.8M)	(2.0M)	(2.2M)	(2.0M)	(2.1M)
Retained Earnings	(44.3M)	(55.6M)	(68.8M)	(79.5M)	(71.6M)	(75.1M)
Accounts Payable	275K	279K	116K	357K	321.3K	489.2K
Cash	19.7M	13.5M	2.4M	2.5M	2.8M	2.7M
Non Current Assets Total	1.0M	888K	723K	406K	365.4K	347.1K
Non Currrent Assets Other	259K	962K	5.0K	(1.0)	(0.9)	(0.85)
Cash And Short Term Investments	24.6M	15.5M	8.2M	6.4M	7.3M	7.0M
Net Receivables	340K	174K	103K	1.3M	1.5M	1.6M
Common Stock Shares Outstanding	7.1M	7.1M	7.3M	10.2M	11.7M	12.3M
Liabilities And Stockholders Equity	26.3M	16.8M	9.5M	8.3M	7.5M	7.1M
Non Current Liabilities Total	626K	402K	179K	40K	36K	34.2K
Other Current Assets	265K	213K	609K	243K	218.7K	207.8K
Other Stockholder Equity	68.5M	69.9M	76.0M	83.9M	96.5M	101.3M
Total Liab	2.0M	2.4M	2.2M	3.8M	3.4M	3.3M
Total Current Assets	25.3M	15.9M	8.8M	7.9M	7.1M	6.8M
Short Term Debt	374K	278K	283K	191K	219.7K	208.7K
Property Plant And Equipment Gross	251.0	1.2M	1.1M	899K	809.1K	768.6K
Short Term Investments	5.0M	2.0M	5.8M	3.9M	3.5M	3.9M
Inventory	(5K)	(174K)	(103K)	(42K)	(37.8K)	(39.7K)
Net Tangible Assets	31.5M	24.3M	14.4M	7.3M	8.4M	11.1M
Property Plant Equipment	228K	1.0M	888K	723K	650.7K	1.2M
Capital Lease Obligations	813K	680K	462K	231K	265.7K	432.7K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Microbot Stock Analysis

When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC